Format

Send to

Choose Destination
J Crohns Colitis. 2019 Jan 1;13(1):139-140. doi: 10.1093/ecco-jcc/jjy135.

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.

Author information

1
Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
2
Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
3
Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
4
Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
5
Pfizer Inc, Collegeville, PA, USA.
6
Optum, Lincoln, RI, USA.
7
Pfizer Inc, Groton, CT, USA.
8
The University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA.

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center